Despite the successes demonstrated in imaging studies, most of the currently available FAP-targeting radiotracers demonstrate a suboptimal tumor retention time in preclinical and clinical studies (Loktev et al. 2019; Kuyumcu et al. 2021; Ballal et al. 2021; Sun et al. 2022). Here, FAP is linked to neoplasm.